These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

194 related articles for article (PubMed ID: 11687713)

  • 21. [The enhancement effects of Gd-DTPA for cerebrospinal lesions-- comparison with conventional T2-weighted images].
    Mano I; Yoshida H; Kono T; Tsuchida T; Terao H; Iio M
    Rinsho Hoshasen; 1987 Dec; 32(13):1547-53. PubMed ID: 3448287
    [No Abstract]   [Full Text] [Related]  

  • 22. Contrast enhanced magnetic resonance imaging of the brain using gadolinium-DTPA.
    Valk J; de Slegte RG; Crezee FC; Hazenberg GJ; Thjaha SI; Nauta JJ
    Acta Radiol; 1987; 28(6):659-65. PubMed ID: 2962597
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Gd-DTPA-enhanced MR imaging of injured spinal cord.
    Terae S; Takahashi C; Abe S; Kikuchi Y; Miyasaka K
    Clin Imaging; 1997; 21(2):82-9. PubMed ID: 9095382
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Contrast-enhanced MR imaging of neurocutaneous melanosis.
    Rhodes RE; Friedman HS; Hatten HP; Hockenberger B; Oakes WJ; Tomita T
    AJNR Am J Neuroradiol; 1991; 12(2):380-2. PubMed ID: 1902050
    [No Abstract]   [Full Text] [Related]  

  • 25. Gadolinium chelates with weak binding to serum proteins. A new class of high-efficiency, general purpose contrast agents for magnetic resonance imaging.
    Cavagna FM; Maggioni F; Castelli PM; Daprà M; Imperatori LG; Lorusso V; Jenkins BG
    Invest Radiol; 1997 Dec; 32(12):780-96. PubMed ID: 9406019
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Dynamic imaging of contrast enhancement in brain tumors.
    Bullock PR; Mansfield P; Gowland P; Worthington BS; Firth JL
    Magn Reson Med; 1991 Jun; 19(2):293-8. PubMed ID: 1881318
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Magnetic resonance imaging contrast agents: theory and application to the central nervous system.
    Bronen RA; Sze G
    J Neurosurg; 1990 Dec; 73(6):820-39. PubMed ID: 2230966
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Technical advances in magnetic resonance imaging.
    Bydder GM
    Curr Opin Neurol Neurosurg; 1992 Dec; 5(6):854-8. PubMed ID: 1467578
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Gadodiamide injection: nonionic gadolinium chelate for MR imaging of the brain and spine--phase II-III clinical trial.
    Greco A; McNamara MT; Lanthiez P; Quay SC; Michelozzi G
    Radiology; 1990 Aug; 176(2):451-6. PubMed ID: 2195593
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Basic physics of MR contrast agents and maximization of image contrast.
    Hendrick RE; Haacke EM
    J Magn Reson Imaging; 1993; 3(1):137-48. PubMed ID: 8428081
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Gadolinium-DTPA enhanced MR imaging of intradural neurenteric cysts.
    Pierot L; Dormont D; Queslati S; Cornu P; Rivierez M; Bories J
    J Comput Assist Tomogr; 1988; 12(5):762-4. PubMed ID: 3170836
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Enhancing transdural lumbar disk herniation.
    Snow RD; Williams JP; Weber ED; Richardson PH
    Clin Imaging; 1995; 19(1):12-6. PubMed ID: 7895189
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Value of fat suppression in gadolinium-enhanced magnetic resonance neuroimaging.
    D'Anjou MA; Carmel EN; Tidwell AS
    Vet Radiol Ultrasound; 2011; 52(1 Suppl 1):S85-90. PubMed ID: 21392161
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Imaging new lesions: enhancing our understanding of multiple sclerosis pathogenesis.
    Fisher E; Reich DS
    Neurology; 2013 Jul; 81(3):202-3. PubMed ID: 23761620
    [No Abstract]   [Full Text] [Related]  

  • 35. Inverse correlation between T1 relaxation times before and after administration of contrast media in malignant brain tumors.
    Niemi P; Aronen HJ; Kwong KK; Gazit IE; Pardo FS; Rosen BR
    Acad Radiol; 1996 Aug; 3 Suppl 2():S286-8. PubMed ID: 8796582
    [No Abstract]   [Full Text] [Related]  

  • 36. Comparison of the safety of standard and triple dose gadodiamide injection in MR imaging of the central nervous system. A double-blind study.
    Svaland MG; Christensen T; Lundorf E
    Acta Radiol; 1994 Jul; 35(4):396-9. PubMed ID: 8011392
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Dynamic contrast-enhanced magnetic resonance imaging of the breast combined with pharmacokinetic analysis of gadolinium-DTPA uptake in the diagnosis of local recurrence of early stage breast carcinoma.
    Mussurakis S; Buckley DL; Bowsley SJ; Carleton PJ; Fox JN; Turnbull LW; Horsman A
    Invest Radiol; 1995 Nov; 30(11):650-62. PubMed ID: 8557506
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Liver I: Currently available gadolinium chelates.
    Mitchell DG
    Magn Reson Imaging Clin N Am; 1996 Feb; 4(1):37-51. PubMed ID: 8673715
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Contrast enhancement in magnetic resonance imaging using intravenous paramagnetic contrast media: a review.
    Kuriashkin IV; Losonsky JM
    Vet Radiol Ultrasound; 2000; 41(1):4-7. PubMed ID: 10695873
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Delayed magnetic resonance hepatic imaging with gadolinium-DTPA.
    Nelson RC; Umpierrez ME; Chezmar JL; Bernardino ME
    Invest Radiol; 1988 Jul; 23(7):509-11. PubMed ID: 3170138
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.